Position in DNTH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$799,325,568
+$147,461,361 QoQ
Shares Held
8,199,893
+5.6% QoQ
Ownership
14.7%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1
of 269 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. DNTH ranks #20 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in DNTH
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $799,325,568 | 8,199,893 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $651,864,207 | 7,767,686 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $265,035,067 | 6,431,329 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $234,944,603 | 5,970,638 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $84,658,221 | 4,544,188 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $81,314,526 | 4,482,609 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $96,776,324 | 4,439,281 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $120,558,191 | 4,403,148 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $113,934,628 | 4,402,420 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $124,831,350 | 4,161,045 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $23,069,404 | 2,218,212 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $30,322,957 | 2,218,212 | Shares | Defined | 2023-11-13 | |
| 2023-03-31 MGTA | — | 254 | Shares | Defined | 2023-08-11 | |
| 2022-09-30 MGTA | — | 570 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 MGTA | — | 770 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 MGTA | — | 509 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 MGTA | — | 745,100 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 MGTA | — | 745,100 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 MGTA | — | 745,100 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 MGTA | — | 672,300 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 MGTA | — | 97,400 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 MGTA | — | 97,400 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 MGTA | — | 97,400 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 MGTA | — | 138,112 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||